Literature DB >> 167722

Properties of phosphoenolpyruvate carboxykinase (guanosine triphosphate) synthesized in hepatoma cells in the presence of amino acid analogues.

S E Knowles, J M Gunn, L Reshef, R W Hanson, F J Ballard.   

Abstract

Phosphoenolpyruvate carboxykinase (GTP) was induced by a combination of dibutyryl cyclic AMP, theophyline and dexamethasone in Reuber H35 hepatoma cells under conditions where an amino acid in the medium was replaced by an appropriate analogue. 2. With canavanine replacing arginine or with 5-fluorotryptophan or 6-fluorotryptophan replacing tryptophan the induced enzyme had a lower catalytic activity-relative to antibody reactivity. 3. These aberrant enzyme molecules were heat-labile in vitro. 4. Measurements of enzyme degradation in vivo indicated that the canavanine-containing enzyme and the 6-fluorotryptophan-containing enzyme were degraded more rapidly than the enzyme containing all natural amino acids.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 167722      PMCID: PMC1165347          DOI: 10.1042/bj1460585

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  15 in total

1.  Increased degradation rates of protein synthesized in hepatoma cells in the presence of amino acid analogues.

Authors:  S E Knowles; J M Gunn; R W Hanson; F J Ballard
Journal:  Biochem J       Date:  1975-03       Impact factor: 3.857

Review 2.  Intracellular protein degradation in mammalian and bacterial cells.

Authors:  A L Goldberg; J F Dice
Journal:  Annu Rev Biochem       Date:  1974       Impact factor: 23.643

3.  Inactive enzyme molecules in aging mice: liver aldolase.

Authors:  H Gershon; D Gershon
Journal:  Proc Natl Acad Sci U S A       Date:  1973-03       Impact factor: 11.205

4.  Purification of phosphoenolpyruvate carboxykinase from the cytosol fraction of rat liver and the immunochemical demonstration of differences between this enzyme and the mitochondrial phosphoenolpyruvate carboxykinase.

Authors:  F J Ballard; R W Hanson
Journal:  J Biol Chem       Date:  1969-10-25       Impact factor: 5.157

5.  Response of intracellular proteolysis to alteration of bacterial protein and the implications in metabolic regulation.

Authors:  M J Pine
Journal:  J Bacteriol       Date:  1967-05       Impact factor: 3.490

6.  Regulation of tyrosine aminotransferase in rat liver. XI. Studies on the relationship of enzyme stability to enzyme turnover in cultured hepatoma cells.

Authors:  R W Johnson; F T Kenney
Journal:  J Biol Chem       Date:  1973-07-10       Impact factor: 5.157

7.  Aging effects on the liver aldolase of rabbits.

Authors:  P J Anderson
Journal:  Biochem J       Date:  1974-05       Impact factor: 3.857

8.  Degradation of phosphoenolpyruvate carboxykinase (guanosine triphosphate) in vivo and in vitro.

Authors:  F J Ballard; M F Hopgood; L Reshef; R W Hanson
Journal:  Biochem J       Date:  1974-06       Impact factor: 3.857

9.  Phosphopyruvate carboxylase induction by L-tryptophan. Effects on synthesis and degradation of the enzyme.

Authors:  F J Ballard; M F Hopgood
Journal:  Biochem J       Date:  1973-10       Impact factor: 3.857

10.  The initial synthesis of proteins during development. Phosphoenolpyruvate carboxylase in rat liver at birth.

Authors:  H Philippidis; R W Hanson; L Reshef; M F Hopgood; F J Ballard
Journal:  Biochem J       Date:  1972-03       Impact factor: 3.857

View more
  3 in total

1.  Increased degradation rates of protein synthesized in hepatoma cells in the presence of amino acid analogues.

Authors:  S E Knowles; J M Gunn; R W Hanson; F J Ballard
Journal:  Biochem J       Date:  1975-03       Impact factor: 3.857

2.  Decreased protein and puromycinyl-peptide degradation in livers of senescent mice.

Authors:  L Lavie; A Z Reznick; D Gershon
Journal:  Biochem J       Date:  1982-01-15       Impact factor: 3.857

3.  Selective control of the degradation of normal and aberrant proteins in Reuber H35 hepatoma cells.

Authors:  S E Knowles; F J Ballard
Journal:  Biochem J       Date:  1976-06-15       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.